a developer of plant traits for the agriculture and biofuel industries
Industry Biotechnology
A.I.dvisor tells us that EVGN and ABOS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVGN and ABOS's prices will move in lockstep.
Ticker / NAME | Correlation To EVGN | 1D Price Change % | ||
---|---|---|---|---|
EVGN | 100% | -6.91% | ||
ABOS - EVGN | 26% Poorly correlated | +3.16% | ||
RARE - EVGN | 25% Poorly correlated | -2.20% | ||
CRVS - EVGN | 25% Poorly correlated | -3.95% | ||
MRUS - EVGN | 24% Poorly correlated | -2.49% | ||
PRTA - EVGN | 24% Poorly correlated | -6.56% | ||
More |
Ticker / NAME | Correlation To EVGN | 1D Price Change % |
---|---|---|
EVGN | 100% | -6.91% |
plastic surgery theme (5 stocks) | 17% Poorly correlated | -1.93% |
stem cells theme (21 stocks) | 14% Poorly correlated | -3.32% |
biotechnology theme (238 stocks) | 13% Poorly correlated | -4.32% |
cancer theme (82 stocks) | 13% Poorly correlated | -5.37% |
drugs theme (254 stocks) | 12% Poorly correlated | -4.03% |
More |